Evidence map›Paper›PMID 34452146›Full record

ArticlePharmaceutics2021

Anti-Melanogenic Mechanism of Tetrahydrocurcumin and Enhancing Its Topical Delivery Efficacy Using a Lecithin-Based Nanoemulsion.

Xudong Tang, Qiaoru Dong, Jun Li, Fang Li, Bozena B Michniak-Kohn, Denggao Zhao, Chi-Tang Ho, Qingrong Huang

Open access · goldAbstract read
In one paragraph

Article in Pharmaceutics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Antioxidants (Basel, Switzerland) · 2025
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Xudong TangDepartment of Food Science, Rutgers University, 65 Dudley Road, New Brunswick, NJ 08901, USA.
Qiaoru DongDepartment of Food Science, Rutgers University, 65 Dudley Road, New Brunswick, NJ 08901, USA.ORCID 0000-0003-3403-2695
Jun LiCollege of Food Science, South China Agricultural University, Guangzhou 510642, China.
Fang LiCollege of Food Science and Engineering, Wuhan Polytechnic University, Wuhan 430023, China.
Bozena B Michniak-KohnCenter of Dermal Research (CDR) and Ernest Mario School of Pharmacy, Life Sciences Building, Rutgers University, Piscataway, NJ 08854, USA.
Denggao ZhaoSchool of Biotechnology and Health Sciences, Wuyi University, Jiangmen 529020, China.
Chi-Tang HoDepartment of Food Science, Rutgers University, 65 Dudley Road, New Brunswick, NJ 08901, USA.ORCID 0000-0001-8273-2085
Qingrong HuangDepartment of Food Science, Rutgers University, 65 Dudley Road, New Brunswick, NJ 08901, USA.
Rutgers, The State University of New Jersey · USSouth China Agricultural University · CNWuhan Polytechnic University · CNWuyi University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tetrahydrocurcumin (THC) has been well known for its superior antioxidant properties. Therefore, it is speculated that it might be effective to relieve oxidative stress-induced diseases, such as skin hyperpigmentation. In this work, an in vitro B16F10 melanoma cell model was used to study the impact of THC on the melanogenic process under stressed conditions. It was demonstrated that THC could effectively inhibit the α-MSH (melanocyte-stimulating hormone) induced melanin production in B16F10 melanoma cells and the expressions of three key enzymes involved with the biosynthetic process of melanin, tyrosinase (TYR), tyrosinase-related protein 1 (TRP-1), and tyrosinase-related protein 2 (TRP-2), were all significantly reduced. In addition, an in vitro human keratinocyte cell model was used to investigate the potential protective role of THC on H

Indexed as

anti-melanogenesisB16F10HaCaTnanoemulsiontetrahydrocurcumintopical delivery

Identifiers

PMID34452146
PMCPMC8397971
OpenAlexW3188347271

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.